Search

Author/Creator Yee, Karen W. L.

2. A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia. Issue 10 (3rd October 2015)

Authors:
How, Jonathan; Minden, Mark D.; Brian, Leber; Chen, Eric X.; Brandwein, Joseph; Schuh, Andre C.; Schimmer, Aaron D.; Gupta, Vikas; Webster, Sheila; Degelder, Tammy; Haines, Patricia; Stayner, Lee-Anne; McGill, Shauna; Wang, Lisa; Piekarz, Richard; Wong, Tracy; Siu, Lillian L.; Espinoza-Delgado, I...
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 10(2015:Oct.)
Page Start:
2793
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. (10th October 2014)

Authors:
Kuo, Kevin H. M.; Callum, Jeannie L.; Panzarella, Tony; Jacks, Lindsay M.; Brandwein, Joseph; Crump, Michael; Curtis, John E.; Gupta, Vikas; Lipton, Jeffrey H.; Minden, Mark D.; Sher, Graham D.; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W. L.; Keating, Armand; Messner, Hans A.
Journal:
British journal of haematology
Issue:
Volume 168:Number 3(2015:Feb.)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. Issue 2 (6th December 2017)

Authors:
Roboz, Gail J.; Kantarjian, Hagop M.; Yee, Karen W. L.; Kropf, Patricia L.; O'Connell, Casey L.; Griffiths, Elizabeth A.; Stock, Wendy; Daver, Naval G.; Jabbour, Elias; Ritchie, Ellen K.; Walsh, Katherine J.; Rizzieri, David; Lunin, Scott D.; Curio, Tania; Chung, Woonbok; Hao, Yong; Lowder, James...
Journal:
Cancer
Issue:
Volume 124:Issue 2(2018)
Page Start:
325
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Issue 4 (3rd March 2014)

Authors:
Minden, Mark D.; Hogge, Donna E.; Weir, Scott J.; Kasper, Jim; Webster, Debra A.; Patton, Lavonne; Jitkova, Yulia; Hurren, Rose; Gronda, Marcela; Goard, Carolyn A.; Rajewski, Lian G.; Haslam, John L.; Heppert, Kathleen E.; Schorno, Kevin; Chang, Hong; Brandwein, Joseph M.; Gupta, Vikas; Schuh, An...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 4(2014:Apr.)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis. (5th July 2017)

Authors:
Leitch, Heather A.; Parmar, Ambica; Wells, Richard A.; Chodirker, Lisa; Zhu, Nancy; Nevill, Thomas J.; Yee, Karen W. L.; Leber, Brian; Keating, Mary‐Margaret; Sabloff, Mitchell; St. Hilaire, Eve; Kumar, Rajat; Delage, Robert; Geddes, Michelle; Storring, John M.; Kew, Andrea; Shamy, April; Elemary...
Journal:
British journal of haematology
Issue:
Volume 179:Number 1(2017)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study. (15th March 2016)

Authors:
Buckstein, Rena; Wells, Richard A.; Zhu, Nancy; Leitch, Heather A.; Nevill, Thomas J.; Yee, Karen W. L.; Leber, Brian; Sabloff, Mitchell; St. Hilaire, Eve; Kumar, Rajat; Geddes, Michelle; Shamy, April; Storring, John; Kew, Andrea; Elemary, Mohamed; Levitt, Max; Lenis, Martha; Mamedov, Alex; Zhang...
Journal:
British journal of haematology
Issue:
Volume 174:Number 1(2016)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived. Issue 1 (2nd January 2018)

Authors:
Farshchi Zarabi, Sara; Chan, Steven; Gupta, Vikas; Khalaf, Dina; Lutynski, Andrzej; Minden, Mark D.; Rostom, Amr; Rydlewski, Anna; Schuh, Andre C.; Sibai, Hassan; Yee, Karen W. L.; Schimmer, Aaron D.
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 1(2018)
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗